摘要
背景:神经炎症在阿尔茨海默病(AD)等多种神经退行性疾病的发病机制中起着重要作用,细胞因子信号传导3(SOCS 3)抑制剂是一种抑制包括小胶质细胞在内的多种细胞内细胞因子信号和炎症基因表达的抗炎分子。 目的:SOCS 3的上调途径尚不清楚,肉桂酸是肉桂的代谢产物,是一种天然化合物,在世界范围内被广泛用作香料或调味剂,本文研究了肉桂酸是否能在小胶质细胞中上调SOCS 3的含量。 方法:用肉桂酸处理小鼠脑内分离的小胶质细胞和星形胶质细胞,用RT-PCR和实时定量PCR检测SOCS 3和不同促炎分子的水平,并进行芯片分析,监测SOCS 3基因启动子上cAMP反应元件结合(CREB)的形成,并对CREB进行siRNA基因敲除。 结果:肉桂酸可上调小鼠BV-2小胶质细胞SOCS 3 mRNA和蛋白的表达,与BV-2小胶质细胞相似,相应地,肉桂酸还能增加LPS刺激的bv-2小胶质细胞的SOCS 3水平,抑制诱导型一氧化氮合酶和促炎细胞因子(TNF-α、IL-1β和IL-6)的表达。与BV-2小胶质细胞相似,肉桂酸也增加了原代小鼠小胶质细胞和星形胶质细胞中SOCS 3的表达。我们已经观察到SOCS 3基因启动子中存在cAMP反应元件,肉桂酸诱导CREB活化,siRNA敲除CREB可使肉桂酸介导的SOCS 3上调,肉桂酸处理导致CREB进入SOCS 3基因。 结论:肉桂酸通过CREB途径上调胶质细胞SOCS 3的表达,可能在神经炎症和神经退行性疾病中起重要作用。
关键词: 肉桂酸、胶质细胞、细胞因子信号抑制物、环磷腺苷效应元件结合蛋白、神经炎症、小胶质细胞。
Current Alzheimer Research
Title:Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid
Volume: 15 Issue: 10
关键词: 肉桂酸、胶质细胞、细胞因子信号抑制物、环磷腺苷效应元件结合蛋白、神经炎症、小胶质细胞。
摘要: Background: Neuroinflammation plays an important role in the pathogenesis of various neurodegenerative diseases including Alzheimer’s disease (AD). Suppressor of cytokine signaling 3 (SOCS3) is an anti-inflammatory molecule that suppresses cytokine signaling and inflammatory gene expression in different cells including microglia.
Objective: The pathways through which SOCS3 could be upregulated are poorly described. Cinnamic acid is a metabolite of cinnamon, a natural compound that is being widely used all over the world as a spice or flavoring agent. Here, we examined if cinnamic acid could upregulate SOCS3 in microglia.
Method: Microglia and astroglia isolated from mouse brain as well as BV-2 microglial cells were treated with cinnamic acid followed by monitoring the level of SOCS3 and different proinflammatory molecules by RT-PCR and real-time PCR. To nail down the mechanism, we also performed ChIP analysis to monitore the recruitment of cAMP response element binding (CREB) to the socs3 gene promoter and carried out siRNA knockdown of CREB.
Results: Cinnamic acid upregulated the expression of SOCS3 mRNA and protein in mouse BV-2 microglial cells in dose- and time-dependent manner. Accordingly, cinnamic acid also increased the level of SOCS3 and suppressed the expression of inducible nitric oxide synthase and proinflammatory cytokines (TNFα, IL-1β and IL-6) in LPSstimulated BV-2 microglial cells. Similar to BV-2 microglial cells, cinnamic acid also increased the expression of SOCS3 in primary mouse microglia and astrocytes. We have seen that cAMP response element is present in the promoter of socs3 gene, that cinnamic acid induces the activation of CREB, that siRNA knockdown of CREB abrogates cinnamic acid-mediated upregulation of SOCS3, and that cinnamic acid treatment leads to the recruitment of CREB to the socs3 gene.
Conclusions: These studies suggest that cinnamic acid upregulates the expression of SOCS3 in glial cells via CREB pathway, which may be of importance in neuroinflammatory and neurodegenerative disorders.
Export Options
About this article
Cite this article as:
Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid, Current Alzheimer Research 2018; 15 (10) . https://dx.doi.org/10.2174/1567205015666180507104755
DOI https://dx.doi.org/10.2174/1567205015666180507104755 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
subject Index To Volume 1
Current Drug Targets - CNS & Neurological Disorders Position Based Nucleotide Analysis of miR168 Family in Higher Plants and its Targets in Mammalian Transcripts
MicroRNA Application of an In Vivo Brain Microdialysis Technique to Studies of Drug Transport Across the Blood-Brain Barrier
Current Drug Metabolism An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Metal Ions and Metal Complexes in Alzheimer’s Disease
Current Pharmaceutical Design Neuroprotection of (+)-2-(1-Hydroxyl-4-Oxocyclohexyl) Ethyl Caffeate Against Hydrogen Peroxide and Lipopolysaccharide Induced Injury via Modulating Arachidonic Acid Network and p38-MAPK Signaling
Current Alzheimer Research Editorial [Hot Topic: Functions and Metabolism of Brain Nucleosides and their Metabolites (Guest Editors: Zsolt Kovacs & Arpad Dobolyi)]
Current Topics in Medicinal Chemistry Nitric Oxide, Epileptic Seizures, and Action of Antiepileptic Drugs
CNS & Neurological Disorders - Drug Targets T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Protective Effects of Pomegranate in Endothelial Dysfunction
Current Pharmaceutical Design Neurotransmitters and Microglial-Mediated Neuroinflammation
Current Protein & Peptide Science Hyper-Homocysteinemia Alters Amyloid Peptide-Clusterin Interactions and Neuroglial Network Morphology and Function in the Caudate After Intrastriatal Injection of Amyloid Peptides
Current Alzheimer Research Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Protein & Peptide Letters Editorial [Pharmacology and Therapeutic Activity of Purinergic Drugs for Disorders of the Nervous System]
CNS & Neurological Disorders - Drug Targets Heat Shock Response Regulates Insulin Sensitivity and Glucose Homeostasis: Pathophysiological Impact and Therapeutic Potential
Current Diabetes Reviews Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease
Current Alzheimer Research EDITOR’S PERSPECTIVE [The Challenges for Drug Development: Cytokines, Genes, and Stem Cells]
Current Neurovascular Research Tau Oligomers as Potential Targets for Immunotherapy for Alzheimers Disease and Tauopathies
Current Alzheimer Research Exosomes Harnessed as Nanocarriers for Cancer Therapy - Current Status and Potential for Future Clinical Applications
Current Molecular Medicine Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer
Current Medicinal Chemistry